GNH USA

Europe — EMA

Mirtastad (Mirtazapine)

GNH USA supplies Mirtastad (Mirtazapine), for major depressive disorder, to hospitals, pharmacies and clinics globally. Request a quote for the supply.

Request sourcing

1
Pack/s

What is Mirtazapine?

Mirtazapine, the active ingredient in Mirtastad, is a NaSSA (noradrenergic and specific serotonergic antidepressant) presented as a tablet for oral use. It treats major depressive disorder in adult patients. GNH USA supplies Mirtastad as a licensed, GDP‑compliant international pharmaceutical supplier serving hospitals, pharmacies and clinics worldwide.

What is Mirtazapine used for?

Mirtastad, a NaSSA antidepressant, is indicated for conditions within the depressive disorder spectrum.

- Major depressive disorder: reduces depressive symptoms and improves mood in adult patients.

What are the side effects of Mirtazapine?

Mirtastad may cause a range of adverse reactions, which are grouped by frequency.

Common Side Effects: - Sedation or drowsiness - Increased appetite and weight gain - Dry mouth - Constipation - Dizziness - Fatigue

Serious or Rare Side Effects: - Agranulocytosis or severe neutropenia - Severe hypersensitivity reactions (rash, angioedema) - Seizures - Suicidal thoughts or behavior - Hepatotoxicity

What precautions apply to Mirtazapine?

Before initiating therapy, clinicians should consider several safety aspects.

- Assess hepatic function: adjust use in patients with liver impairment. - Monitor for suicidal ideation: especially during early treatment. - Use caution in cardiovascular disease: watch for orthostatic hypotension. - Avoid abrupt discontinuation: taper to reduce withdrawal symptoms. - Adjust dose in renal impairment: consider reduced clearance. - Store at ambient temperature: keep below 25°C, retain in original packaging, protect from moisture.

What does Mirtazapine interact with?

Mirtastad can interact with other medicines, requiring attention to the interaction strength.

Major Interactions (Avoid): - MAO inhibitors: risk of hypertensive crisis. - Other serotonergic agents (e.g., SSRIs, SNRIs): potential serotonin syndrome. - CNS depressants (e.g., benzodiazepines, alcohol): enhanced sedation.

Moderate Interactions (Monitor Closely): - CYP2D6 inhibitors (e.g., fluoxetine, paroxetine): may increase mirtazapine levels. - Carbamazepine: may reduce mirtazapine exposure. - Antihypertensives: additive blood‑pressure lowering effect.

Frequently asked questions

What is Mirtastad used for?+
Mirtastad contains the active ingredient mirtazapine and is prescribed to treat major depressive disorder in adult patients. It helps alleviate depressive symptoms such as low mood, loss of interest, and associated anxiety.
How does mirtazapine work?+
Mirtazapine works by blocking presynaptic alpha‑2 adrenergic receptors, which increases the release of norepinephrine and serotonin. It also antagonizes specific serotonin (5‑HT2, 5‑HT3) and histamine (H1) receptors, enhancing mood and providing a sedative effect.
What is the usual dose of Mirtastad?+
The appropriate dose of Mirtastad is determined by the prescribing clinician based on the patient’s clinical condition, response, and tolerability. Dosage may be adjusted over time, and patients should follow the prescriber’s instructions exactly.
Is Mirtastad safe during pregnancy or breastfeeding?+
Safety data for mirtazapine in pregnancy and lactation are limited. The medication should only be used if the potential benefit justifies any possible risk to the fetus or infant, and decisions should be made in consultation with a healthcare professional.
How do I order Mirtastad from GNH USA?+
To place an order, submit an enquiry on the product page at gnh-usa.com, specifying the required quantity. GNH USA works with hospitals, pharmacies and procurement teams worldwide, verifies trade or institutional credentials, and then provides pricing, availability, shipping details and any necessary import documentation.
How does Mirtastad compare with other antidepressants?+
Mirtastad (mirtazapine) belongs to the NaSSA class, differing from SSRIs and SNRIs by its dual antagonism of alpha‑2 adrenergic and specific serotonin receptors. This mechanism often results in a distinct side‑effect profile, including higher rates of sedation and weight gain, which may be advantageous for patients with insomnia or appetite loss.
What are the storage and handling requirements for Mirtastad?+
Mirtastad tablets should be stored at ambient temperature, below 25 °C, in their original packaging to protect from moisture and light. Keep the product out of reach of children and do not use after the expiry date.
How is Mirtastad administered?+
Mirtastad is taken orally as a tablet, usually once daily in the evening. The tablet should be swallowed whole with water and not chewed or crushed, unless otherwise directed by a healthcare professional.
What are the most serious risks associated with Mirtastad?+
Serious risks include agranulocytosis, severe hypersensitivity reactions, seizures, and the emergence or worsening of suicidal thoughts, particularly during the initial weeks of therapy. Patients should be monitored closely for any signs of these conditions.
Who should not use Mirtastad?+
Mirtastad is contraindicated in patients with known hypersensitivity to mirtazapine or any of its excipients, and in those currently taking monoamine oxidase inhibitors (MAOIs). Caution is also advised for individuals with severe hepatic impairment, uncontrolled cardiovascular disease, or a history of seizures.
Information provided on this page is for educational use by procurement and clinical professionals. Always consult a licensed healthcare provider for medical advice and prescribing decisions. GNH USA supplies this product subject to applicable regulatory and licensing requirements.

Product details

Drug
Mirtazapine
Route
Oral Use
Manufacturer
Stada Arzneimittel Ag
Origin
EU

Related products